Cardiex Awarded $525,000 Grand Prize In NIH Radx Tech For Maternal Health Challenge
The NIH RADx Tech for Maternal Health Challenge was launched to address critical health disparities for postpartum women, particularly those living in maternity care deserts. Cardiex's submission, which enables non-invasive monitoring of central blood pressure and other key arterial parameters, is designed to reduce cardiovascular morbidity in postpartum women by offering clinically valuable insights that go beyond traditional blood pressure measurement.
"We are honored to receive this award and to be recognized for our commitment to advancing maternal health," said Craig Cooper, CEO of Cardiex. "Our Pulse and Band technologies provide essential arterial health insights, offering healthcare providers and patients a deeper understanding of cardiovascular risks during the postpartum period. This recognition validates our efforts to close critical gaps in maternal care, and we look forward to expanding access to these life-saving technologies."
The NIH's RADx Tech for Maternal Health Challenge is part of the IMPROVE Initiative (Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone), which seeks to address the maternal mortality crisis by accelerating the development of innovative diagnostic tools and solutions. Cardiex's prize-winning technology will play a crucial role in providing critical health data to postpartum women in underserved communities.
The public announcement of the award will take place at the 5th Anniversary Meeting of the IMPROVE Initiative on Tuesday, October 15th, 2024.
For more information on Cardiex
and its innovative health technologies, please visit .
SOURCE Cardiex Limited
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment